摘要
目的研究血管生成素-2(Ang-2)在肝细胞癌(HCC)组织中表达及其在判断预后中的价值。方法对随访的60例原发性肝癌临床资料进行回顾性分析,通过免疫组织化学方法检测Ang-2在癌组织中的表达情况。研究其与病理因素、组织学分化程度的相关性,并分析Ang-2表达与生存期的关系。结果Ang-2表达率为70%;Ang-2表达与病理因素无关(P〉0.05),与组织学分化程度相关(Х^2=5.424,P=0.025);Ang-2高表达中低分化比例高(66.7%)。高表达组和低表达组患者的1、3、5年无瘤生存率分别为50.0%、33.3%、16.7%和89.6%、50.0%、25.0%(Х^2=6.477,P=0.021)。高表达患者无瘤生存期明显低于低表达患者。结论Ang-2表达多寡与HCC组织分化程度相关,与病理因素无关;Ang-2高表达者生存期低。Ang-2是肝癌切除术后判定预后的预测因子。
Objective To study the relationship between the expression of angiopoietins-2 (Ang-2) and prognosis in hepatocellular carcinoma (HCC) after hepatic resection. Methods Sixty patients with primary liver cancer were retrospectively analyzed and the expression of Ang-2 in carcinoma tissues were assayed by immunohistochemical staining. The interrelationships among the expression of Ang-2, clinicopathological factors and the grade of differentiation of HCC cells were studied. The relationship between the expressions Of Ang-2 and survival time was analysed. Results The expression rate of Ang-2 was 70%. Ang-2 staining had no correlation with clinicopathological factors ( P 〉 0.05 ), but it had a significant correlation with the grade of differentiation of HCC'cells ( Х^2 = 5. 424, P = 0. 025 ). Ang-2 of moderately and poorly differentiated HCC were higher (66.7%) than those of well-differentiated HCC. The disease-free survival rates of patients with high Ang-2 expression and low Ang-2 expression were 50% (1-year), 33.3% (3-year), 16.7% (5-year)and 89.6% (1-year), 50.0% (3-year), 27.1% (5-year), respectively. The disease-free survival of patients with high Ang-2 expression were significantly less than those of patients with low Ang-2 expression ( Х^2 = 6. 477, P = 0. 021 ). Conclusion The expressions of Ang-2 are correlated with the grade of differentiation of HCC cells, but are not correlate with clinicopathological factors. The survivals of patients with Ang-2 high expression are lower than those of low expression. Ang-2 is a significant predictive factor for recurrence after hepatic resection in HCC patients.
出处
《国际肿瘤学杂志》
CAS
2013年第7期552-556,共5页
Journal of International Oncology
基金
吉林省自然科学基金(201215217)
吉林省发改委产业技术研究与开发项目(JF2012C006-6)
吉林省发改委高技术产业发展项目(JF2012C012)
关键词
血管生成素2
癌
肝细胞
免疫组织化学
Angiopoietin-2
Carcinoma, hepatocellular
Immunohistochemistry